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Abstract 
Clinical perfectionism is characterized by imposing excessively high standards on oneself and 
experiencing severe distress when standards are not met. It has been found to contribute to the 
development and maintenance of various clinical presentations including anxiety, obsessive-
compulsive, and eating disorders. The present study tested the efficacy of ten weekly individual 
sessions of acceptance and commitment therapy (ACT) relative to a waitlist control on clinical 
perfectionism and global outcomes among 53 individuals with clinical perfectionism. ACT is a 
process-based therapy that targets maladaptive underlying processes (e.g., rigid adherence to 
unrealistic high standards) rather than symptom topography (e.g., anxiety, depression). 
Participants completed assessments at pretreatment, posttreatment, and one-month follow-up. 
Results indicated compared to the waitlist condition, the ACT condition led to greater 
improvements in clinical perfectionism as well as outcomes related to wellbeing, functional 
impairment, distress, and processes of change. Our study suggests targeting core dysfunctional 
processes (i.e., clinical perfectionism) rather than symptom topography with treatments like ACT 
is feasible and efficacious, supporting a shift from symptom-focused to process-based care. We 
also note potential weaknesses in our treatment protocol and study methodology that should be 
addressed in future research. Study limitations included a small sample size and high dropout 
rate (35.7%). 
Keywords: acceptance and commitment therapy, clinical perfectionism, randomized 
controlled trial, psychological inflexibility, self-compassion  
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A Randomized Controlled Trial of Acceptance and Commitment Therapy for  
Clinical Perfectionism 
 Perfectionism has been conceptualized as a multidimensional construct that entails 
striving for high standards and experiencing distress when these standards are not met (Shafran 
& Mansell, 2001). Perfectionism is not inherently problematic; it has adaptive and maladaptive 
qualities. Researchers have demonstrated evidence for a two-factor measure of perfectionism that 
includes maladaptive evaluative concerns and positive striving (Bieling, Israeli, & Antony, 
2004). The maladaptive evaluative concerns factor was related to anxiety, depression, and 
distress whereas the positive striving factor was not, indicating perfectionistic traits that foster 
excellence and achievement can be adaptive and contribute to the wellbeing of individuals with 
perfectionistic qualities.  
Maladaptive (clinical) perfectionism is defined by rigid adherence to unrealistic self-
imposed standards that interferes with functioning and/or causes the individual significant 
distress (Shafran & Mansell, 2001). Clinical perfectionism is a risk and maintenance factor in a 
wide range of dysfunctional and pathological behaviors including anxiety, depression, obsessive-
compulsive behavior, problematic eating behavior, self-harm, suicidal ideation, and general 
distress (Egan, Wade, & Shafran, 2011; Limburg, Watson, Hagger, & Egan, 2017). Because it is 
a process common across diagnostic labels (Egan et al., 2011), clinical perfectionism can be used 
to characterize a range of diagnoses and simplify case conceptualization by focusing on the 
function rather than the form of behaviors. Clinical perfectionism has also been shown to 
interfere with treatment of these problematic behaviors (Chik, Whittal, & O’Neill, 2008; Jacobs 
et al., 2009; Welch, Miller, Ghaderi, & Vaillancourt, 2009), underscoring the importance of 
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addressing clinical perfectionism even when it is not identified as the primary presenting 
concern. 
 Despite the important role clinical perfectionism appears to play in psychopathology and 
its treatment, few treatments identify clinical perfectionism as the primary intervention target. 
The most empirically supported intervention for clinical perfectionism is cognitive-behavioral 
therapy for clinical perfectionism (CBT-P). CBT-P generally attempts to change dysfunctional 
beliefs related to self-imposed standards through techniques like behavioral experiments and 
cognitive restructuring. CBT-P has produced clinically significant improvements in clinical 
perfectionism (Handley, Egan, Kane, & Rees, 2015; Riley, Lee, Cooper, Fairburn, & Shafran, 
2007; Shafran et al., 2017; Steele et al., 2013), with a recent meta-analysis of eight studies 
finding medium to large pooled effect sizes for improvements in measures of clinical 
perfectionism (Lloyd, Schmidt, Khondoker, & Tchanturia, 2015). Despite empirical support for 
symptomatic improvement following CBT-P, there remains limited understanding of how other 
indices of outcome like functioning and wellbeing are impacted by these interventions. Given 
that absence of psychopathology does not necessarily reflect presence of positive mental health 
(Keyes, 2005), it is important for outcome studies to test if improvement in symptoms are also 
accompanied by gains in psychological wellbeing. Furthermore, another limitation of the extant 
literature is only procedures from a traditional cognitive-behavioral perspective have been tested, 
precluding examination of other therapeutic methods that may be helpful to consider in 
treatment. Identifying alternative therapeutic procedures provides clinicians with more options 
for treatment delivery. 
Targeting the function or effect of maladaptive processes rather than their content 
provides an alternative approach to treating clinical perfectionism. In this iteration of 
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intervention, therapy is aimed at process-based patterns (e.g., avoidance of perceived failure) and 
skills taught tend to address those underlying patterns. Acceptance and commitment therapy 
(ACT; Hayes, Strosahl, & Wilson, 2011) is a modern cognitive-behavioral therapy grounded in 
contextual behavioral science and influenced by acceptance and mindfulness principles. ACT is 
a process-based or functional psychotherapy that relies heavily on identification of underlying 
processes for case conceptualization (Hayes, Luoma, Bond, Masuda, & Lillis, 2006; Hayes et al., 
2011). The ultimate goal of ACT is to enhance valued living and not to reduce symptoms per se. 
As such, theoretically consistent outcomes in ACT trials include indices of wellbeing like values-
consistent behaviors (valued action), quality of life, life satisfaction, and overall functioning 
(Hayes et al., 2011). 
From an ACT perspective, clinical perfectionism is conceptualized as unhelpful 
(typically avoidant) responses to unwanted inner experiences (e.g., procrastinating to avoid 
feeling overwhelmed, overworking to dispel thoughts like “I’m not good enough”) and 
overregulation of behavior by rules (e.g., “I should be getting straight As,” “I should please my 
parents”). ACT has the potential to influence perfectionistic behavioral patterns with a unique 
perspective on how to address “dysfunctional” perfectionistic verbal processes (e.g., thoughts, 
rules, feelings). From an ACT framework, such thoughts⎯or inner experiences more 
broadly⎯have no inherent power to affect behavior and do not need to be altered. Thus, ACT 
focuses on changing the effect of the perfectionistic thought on behavior without necessarily 
changing the content of the thought.  
In contrast, CBT-P posits a different maladaptive process and means of addressing the 
target process: CBT-P identifies dichotomous thinking as a critical mediator between 
perfectionism and psychopathology and focuses on changing the content of the thought to reduce 
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its influence on behavior (Egan et al., 2014; Hofmann & Asmundson, 2008). At the same time, 
we note CBT-P indirectly addresses avoidance through use of behavioral 
experiments⎯necessitating contact with previously avoided stimuli⎯but with the goal of 
challenging irrational thoughts and aligning them more closely with reality (Egan et al., 2014; 
Hofmann & Asmundson, 2008). 
Conversely, ACT works to build skills that undermine the perceived “causal” relationship 
between inner events and behavior so individuals can allow inner experiences to be present as 
they are while still engaging in personally meaningful behavior. The ability to do so is termed 
psychological flexibility⎯the key mechanism of change in ACT (Hayes et al., 2006). Given the 
critical role psychological flexibility is hypothesized to play in ACT, testing if ACT actually 
shifts psychological flexibility provides an important test of theory. If ACT produces 
improvements in outcome without moving psychological flexibility, then the theoretical model 
on which ACT is based needs to be revised. Although this is not a sufficient test of theory as 
ACT may simultaneously shift other processes of change (e.g., cognitive change) that ultimately 
influence outcomes, establishing that ACT shifts its hypothesized process of change would 
provide at least preliminary support for the theory underlying ACT. 
Psychological inflexibility has been found to mediate the relationship between 
maladaptive perfectionism and depression as well as anxiety in cross-sectional and longitudinal 
investigations (Moroz & Dunkley, 2015, 2019), suggesting inflexible responding to 
perfectionistic internal experiences (e.g., self-critical thoughts) may explain how maladaptive 
perfectionism is linked to psychological symptoms. Specifically, these findings suggest more 
engagement in inflexible responding to perfectionism-related stimuli increases depression and 
anxiety over time (Moroz & Dunkley, 2019), supporting the hypothesized paradoxical effect of 
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attempts to regulate distress (i.e., attempts to control distress tend to exacerbate it; Hayes, 
Wilson, Gifford, Follette, & Strosahl, 1996). Given ACT targets psychologically inflexible 
responding, it should lead to reductions in distress among individuals with clinical 
perfectionism⎯even though the explicit goal of ACT is to increase valued living. 
Psychological inflexibility has also been associated with problematic behaviors related to 
clinical perfectionism such as eating disorders, obsessive-compulsive and related disorders, 
depression, and anxiety disorders (A-Tjak et al., 2015; Powers, Zum Vorde Sive Vording, & 
Emmelkamp, 2009), further suggesting clinical perfectionism may be treated by improving 
psychological flexibility. Other support for this hypothesis comes from clinical trials 
demonstrating positive outcomes from ACT for multiple behavioral problems related to clinical 
perfectionism, including obsessive-compulsive disorder (OCD; Twohig et al., 2018; Twohig et 
al., 2010), trichotillomania (Lee et al., 2018), anxiety and depression (Arch et al., 2012; Forman, 
Herbert, Moitra, Yeomans, & Geller, 2007), and problematic eating (Juarascio, Forman, & 
Herbert, 2010). However, ACT has not been specifically tested as a treatment for clinical 
perfectionism.  
The aim of the current study was to investigate the potential efficacy of ACT as a 
treatment for clinical perfectionism using a randomized controlled trial of ACT versus a waitlist 
control. We predicted: (1) levels of clinical perfectionism would significantly decrease from 
pretreatment to follow-up in the ACT condition compared to the waitlist control condition; (2) 
valued action, quality of life, and symptom distress/functional impairment would significantly 
improve from pretreatment to follow-up in the ACT condition compared to the waitlist control 
condition; (3) psychological inflexibility would significantly decrease from pretreatment to 
ACT FOR PERFECTIONISM 8 
follow-up in the ACT condition compared to the waitlist control condition; and (4) participants 
in the ACT condition would give high treatment acceptability ratings. 
Method 
Participants 
 Participants were recruited from a western U.S. town using newspaper advertisements, 
flyers posted in the community and on the local university campus, and announcements in 
university classes. Recruitment materials specified intervention targets as “procrastination, 
spending a lot of time planning/organizing, and difficulty starting/completing tasks because you 
need to get them exactly right.” Inclusion criteria were: (1) score of at least five on the 
Dimensional Obsessive-Compulsive Scale (DOCS) Symmetry subscale as an indicator of 
elevated clinical perfectionism (Abramowitz et al., 2010), (2) reported significant distress and/or 
functional impairment associated with clinical perfectionism based on a clinical interview, (3) 
willingness to complete ten sessions of therapy, (4) cognitively and physically able to complete 
intervention and assessments, (5) not currently seeking therapy for clinical perfectionism, and (6) 
no change in psychotropic medication in the past 30 days. 
Procedures 
 Procedures were reviewed and approved by a university institutional review board. 
Individuals interested in the study completed screening online (criterion 1) and over the phone 
(criteria 3-6) to ascertain they met initial eligibility criteria. Those eligible for the study were 
scheduled for a baseline assessment during which criterion 2 was evaluated. Prior to the baseline 
assessment, participants reviewed and signed an informed consent form. After the baseline 
assessment was completed and study eligibility was confirmed, participants were randomly 
assigned to the treatment or waitlist condition using a random number table with an equal 
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number of odd and even numbers representing each treatment condition. This was done to ensure 
roughly equivalent group sizes. The researcher responsible for random assignment was unaware 
of the condition to which participants would be assigned until the actual assignment was 
conducted.  
Participants in the treatment condition received ten weekly sessions of ACT and 
participants in the waitlist condition were on a 14-week waitlist. Study assessments were 
conducted at pretreatment, each session, posttreatment (10 weeks after pretreatment), and one-
month follow-up. Participants completed self-report measures at all assessment points and 
functional near-infrared spectroscopy neuroimaging at pretreatment and posttreatment. 
Neuroimaging and session data were not included in this report. The waitlist group was offered 
ten sessions of ACT after follow-up data were collected. Students in eligible classes received 
research course credit for their participation in the study. Figure 1 provides an illustration of 
participant flow throughout the study. 
Intervention 
 Treatment consisted of ten weekly 50-minute sessions of ACT. The first session covered 
limits to confidentiality, informed consent (orientation to therapy), and information gathering. 
The second session focused on creative hopelessness. Sessions 3 and 4 were on 
acceptance/willing, 5 and 6 on defusion, and 7 and 8 on values and committed action. The final 
two sessions reviewed skills learned and discussed maintenance of gains and relapse prevention. 
Sessions were conducted by a clinical psychologist who has been licensed for more than 10 years 
or one of two graduate students who were supervised by the psychologist on a weekly basis. 
Sessions were recorded to evaluate treatment integrity.   
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The study treatment manual was based on an ACT protocol for OCD (Twohig et al., 
2010). Because ACT is a process-based therapy, much of the manual adaptation entailed 
replacing the distressing internal experience of obsessions in OCD with experiences relevant to 
participants’ perfectionistic presentation such as fear of failure and a perceived need to be 
“perfect.”  In addition, other considerations were detailed for features specific to clinical 
perfectionism. First, individuals struggling with clinical perfectionism may not exhibit 
significant functional impairment. That is, they may still be able to complete tasks at 
work/school and maintain satisfactory interpersonal relationships. However, they may 
experience significant psychological distress in the form of worry, anxiety, rumination, and self-
critical thoughts and may be acting in accordance with rules that do not align with their values. 
Furthermore, even if they are highly functional, their pattern of behavior may not be sustainable 
or enjoyable over time. Second, because there is a distinction between adaptive and maladaptive 
perfectionism, treatment needed to focus on the maladaptive aspects of perfectionism and not 
perfectionism in general. For example, having high standards per se may be adaptive, but the 
cognitive and behavioral rigidity with which one regards those standards (e.g., “If I don’t get an 
A, I’m a failure”) may not be. Furthermore, the function of the behavior⎯not its 
topography⎯defines whether it is adaptive. For instance, completing homework to avoid 
feelings of inadequacy is likely less adaptive than doing so to approach a value of learning. This 
makes training awareness of the function of behavior a critical component of ACT for clinical 
perfectionism. Third, perfectionism is typically ego-syntonic and individuals may show 
resistance to changing what they view as a dimension of their personality. From an ACT 
perspective, fusion with perfectionism that interferes with valued living is viewed as a form of 
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self-as-content (as opposed to self-as-context). Hence, one potential component of treatment was 
to practice holding this aspect of identity “more lightly” in the service of values.  
Measures 
 Screening measure. 
 Dimensional Obsessive-Compulsive Scale (DOCS)—Symmetry (Abramowitz et al., 
2010). This five-item subscale assesses severity of avoidance, distress, and interference due to a 
perceived need to make things “just right” (Abramowitz et al., 2010). Examples of this type of 
avoidance and/or distress include a perceived need for “symmetry, evenness, balanced, or 
exactness” and behavioral repetition to obtain a feeling of being “just right” or “balanced.” 
Given the overlap between rigid pursuit of a sense of “just right” in the DOCS Symmetry 
subscale and the behavioral inflexibility around arbitrarily imposed standards in clinical 
perfectionism, we used the DOCS Symmetry subscale to screen for clinical perfectionism in the 
current study. Each item is scored from 0 to 4 with higher scores indicating higher severity 
(Abramowitz et al., 2010). Individuals who scored at least five (just below the mean of 6.13 [SD 
= 5.50] in an OCD sample; Abramowitz et al., 2010) were assessed further for eligibility. A 
lower screening cutoff was selected to err on the side of over-including potential participants for 
further eligibility assessment. The symmetry subscale has shown good to excellent internal 
consistency in both clinical and unscreened samples and good convergent, divergent and 
criterion validity (Abramowitz et al., 2010). 
 Baseline measures. 
 Demographics. Participants were asked a series of demographic questions, including 
items on gender, race, ethnicity, and socioeconomic status. 
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 Structured Clinical Interview for DSM-5 (SCID-5; First, Williams, Karg, & Spitzer., 
2016). The SCID-5 is a semi-structured interview used to assess DSM-5 diagnoses, including 
mood and anxiety disorders, psychotic disorders, and substance use disorders. In the current 
study, we administered a truncated version of the SCID-5 focusing on diagnoses related to 
clinical perfectionism: social anxiety disorder, generalized anxiety disorder (GAD), OCD, 
hoarding disorder, body dysmorphic disorder, trichotillomania, excoriation disorder, anorexia 
nervosa, bulimia nervosa, binge-eating disorder, and obsessive-compulsive personality disorder 
(OCPD). Diagnostic interviews were conducted by trained research assistants and diagnoses 
were assigned in accordance with DSM-5 criteria. 
 Outcome measures. 
 Frost Multidimensional Perfectionism Scale (FMPS; Frost, Marten, Lahart, & 
Rosenblate, 1990). The FMPS includes six subscales. However, for the present study only the 
most clinically relevant three subscales indicative of maladaptive perfectionism were analyzed: 
Concern Over Mistakes (9 items), Doubts About Actions (4 items), and Personal Standards (7 
items). Previous treatment trials for clinical perfectionism also used these subscales to evaluate 
outcomes (e.g., Egan et al., 2014; Handley et al., 2015; Riley et al., 2007). The Concern Over 
Mistakes subscale assesses unhelpful responses to mistakes and viewing mistakes as personal 
failure, Doubts About Actions evaluates doubts about personal competence, and Personal 
Standards reflects setting high personal standards and basing self-evaluation on ability to meet 
these standards. We analyzed Personal Standards in this study to provide a comparison to 
previous trials although we note that this subscale appears to be less sensitive to treatment effects 
(Egan et al., 2014; Handley et al., 2015) and has been linked to healthy perfectionism (Bieling et 
al., 2004; Stoeber & Otto, 2006). Each item is scored from 1 to 5 with higher scores indicating 
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more maladaptive perfectionism. This measure has shown construct validity and adequate 
internal consistency (Frost et al., 1990). In our sample, internal consistency was good to 
excellent across the three subscales; Cronbach’s s ranged from .85 to .94. 
 Outcome Questionnaire-45.2 (OQ-45; Lambert et al., 1996). The OQ-45 is a 45-item 
measure of symptom distress and functional impairment (Lambert et al., 1996). Each item is 
scored from 0 to 4 and higher scores indicate greater distress and/or impairment (Lambert et al., 
1996). The full measure has excellent internal consistency and good temporal stability and 
convergent validity (Lambert et al., 1996). Internal consistency was excellent in the present 
sample ( = .94). 
 Quality of Life Scale (QOLS; Burckhardt & Anderson, 2003; Flanagan, 1978). The 
revised 16-item version of the QOLS (Burckhardt & Anderson, 2003) was used in the present 
study to assess overall satisfaction with quality of life. Each item is rated from 1 to 7 with higher 
scores indicating greater quality of life (Burckhardt & Anderson, 2003). The QOLS has 
demonstrated reliability and convergent and divergent validity (Burckhardt & Anderson, 2003). 
In the present study, internal consistency was good ( = .89). 
 Valuing Questionnaire (VQ)—Progress (Smout, Davies, Burns, & Christie, 2014). The 
5-item Progress subscale was used in the current study to assess progress toward personal values. 
Items are rated from 0 to 6; higher scores indicate more valued action (Smout et al., 2014). The 
Progress subscale has demonstrated convergent and incremental validity as well as good internal 
consistency in past research (Smout et al., 2014). Internal consistency was good in this study ( 
= .81). 
 Process measures. 
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Acceptance and Action Questionnaire ⎯ II (AAQ-II; Bond et al., 2011). The AAQ-II is 
a seven-item measure of psychological inflexibility, the process wherein individuals disengage 
from actions in line with personal values due to disconnection from the present moment and/or 
ineffective attempts to control thoughts and feelings (Bond et al., 2011). Each item is scored 
from 1 to 7. Higher scores indicate higher psychological inflexibility. The AAQ-II has 
demonstrated adequate reliability and validity in both clinical and unscreened samples (Bond et 
al., 2011) and is sensitive to treatment (e.g., Fledderus, Bohlmeijer, Pieterse, & Schreurs, 2012). 
In the current study internal consistency was excellent ( = .92). 
Self-Compassion Scale (SCS; Neff, 2003). The SCS is a 26-item measure of self-
compassion. Each item is scored from 1 to 5. A total sum score is calculated from items 
assessing three components of self-compassion (i.e., mindfulness, self-kindness, and common 
humanity) as well as reverse-scored items that measure their inverse (i.e., over-identification, 
self-judgment, and isolation). The scale has excellent internal consistency and strong evidence of 
convergent and divergent validity (Neff, 2003). Internal consistency was excellent in our sample 
( = .95). 
Treatment Acceptability 
 Treatment Evaluation Inventory—Short Form (TEI-SF; Kelley, Heffer, Gresham, 
& Elliot, 1989). The TEI-SF is a nine-item measure of the degree to which clients find a 
psychological intervention acceptable (Kelley et al., 1989). The present study used a seven-item 
version of the TEI-SF; items were revised and two were omitted due to irrelevance to an adult 
sample. Each item is scored from 1 to 5; higher scores indicate greater treatment acceptability 
(Kelley et al., 1989). The measure has good internal consistency and has been found to detect 
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differences between treatments in previous research (Kelley et al., 1989). Internal consistency 
was good in our sample ( = .80). 
Treatment Adherence  
A fifth of all possible therapy sessions (n = 38) from the 19 participants who attended at 
least five sessions were randomly selected to be coded for treatment adherence (Plumb & 
Vilardaga, 2010). Sessions from one participant who completed five sessions were excluded due 
to irretrievable data (broken disc). Selection was balanced within and across participants such 
that two sessions from each participant and at least three of each therapy session were coded to 
ensure fair representation of participants over the course of treatment. Treatment adherence was 
scored based on a standardized coding system used in previously published ACT randomized 
controlled trials (e.g., Crosby & Twohig, 2016; Twohig et al., 2010).  
Raters were trained research assistants who coded at least nine sessions with an 
experienced graduate student who had used the current adherence coding system in previous 
clinical trials. After each session, raters discussed scores assigned and discrepancies were 
discussed to increase consistency between raters. Raters also watched at least one therapy session 
together and coded the session simultaneously to clarify definition of constructs and use of the 
coding scheme. ICCs ranged from .83 to 1.00 for Rater 1 and .79 to 1.00 for Rater 2. By the end 
of the training period, both raters received at least two consecutive ICCs > .90. The remaining 
sessions were independently coded by the two trained raters. 
ACT-congruent and ACT-incongruent processes were coded for quality and quantity on a 
five-point scale (1 = the process was never explicitly covered, 2 = the process occurred at least 
once and not in an in-depth manner, 3 = the process occurred several times and was covered at 
least once in a moderately in-depth manner, 4 = the process occurred with relatively high 
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frequency and was addressed in a moderately in-depth manner, 5 = the process occurred with 
high frequency and was covered in a very in-depth manner). ACT-congruent processes included 
acceptance, defusion, contact with the present moment, self-as-context, committed action, and 
values. ACT-inconsistent processes included cognitive restructuring, attribution of causal power 
to internal experiences, and control/avoidance strategies. In addition, raters provided overall 
ratings for adherence to the ACT model and general quality of therapy. 
Data and Statistical Analyses 
 Data were collected from participants who were willing to complete pretreatment, 
posttreatment, and follow-up assessments, including those who did not attend all ten sessions of 
therapy. All participants assigned to a study condition were included in analyses. Calculation of 
sample size was based on previous clinical trials on perfectionism that reported significant 
effects (e.g., Egan et al., 2014; Riley et al., 2007) due to insufficient information on parameters 
(e.g., intra-individual correlations) required to conduct a priori power analyses for multilevel 
modeling. Use of multilevel models permitted inclusion of all data from this intent-to-treat 
sample irrespective of missing data at posttreatment or follow up. Therefore, no data imputation 
methods were used. Statistical analyses were conducted with R in RStudio (R Core Team, 2015; 
RStudio Team, 2015) using the following packages: tidyverse (Wickham, 2017), lme4 (Bates, 
Maechler, Bolker, & Walker, 2015), effsize (Torchiano, 2017), and texreg (Leifeld, 2013). 
Between-group comparisons (t-test or 2 test) were used to evaluate differences between 
ACT and waitlist participants at pretreatment as well as between treatment completers and 
dropouts. Participants who did not complete at least six sessions of treatment were considered 
dropouts.  
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Linear mixed effects models were used to examine the effect of the intervention 
condition on outcomes over time. A series of nested models were specified for each outcome of 
interest: FMPS-CM, FMPS-PS, FMPS-DA, OQ-45, QOLS, VQ Progress, AAQ-II, and SCS. All 
models included random intercepts for individuals. For all outcomes, the first model only 
included time, where time was measured in three discrete values (i.e., pretreatment, 
posttreatment, and follow-up). The second model added the condition as a main effect. In the 
third and final model, the interaction between time and condition was tested. These models were 
compared in terms of fit using a 2 difference test based on the likelihood function. Only 
coefficients from the best-fitting model were interpreted. Final models were estimated using the 
maximum likelihood criterion. All coefficient p-values reported are based on the Satterthwaite 
approximation to degrees of freedom. 
Clinically Significant and Reliable Change 
 Three different indices of change were used to categorize participants at posttreatment 
and one-month follow-up (see Table 4). 
Clinically significant change. Clinically significant change was operationalized as 
having scores fall within functional range at posttreatment (i.e., one standard deviation from a 
normative mean; Shafran et al., 2017). This is a stricter criterion than that of two standard 
deviations within a normative mean proposed by Jacobson and Truax (1991). For these analyses, 
we only examined the primary (most clinically relevant) variable in each domain of interest— 
clinical perfectionism (FMPS-CM), overall clinical severity (OQ-45), and wellbeing (QOLS). 
The healthy cutoff was < 26 for FMPS-CM (Frost & Steketee, 1997), < 66 for OQ-45 (Lambert 
et al., 1996), and > 71 for QOLS (Langeland, Wahl, Kristoffersen, Nortvedt, & Hanestad, 2007).  
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Reliable change index. We also calculated a reliable change index (RCI)⎯the difference 
between pretreatment and posttreatment scores and between pretreatment and follow-up scores 
divided by the standard error of the difference between the two scores (Jacobson & Truax, 1991). 
An RCI greater than 1.96 suggests real change rather than change due to random error (Jacobson 
& Truax, 1991). Whereas clinically significant change measures proximity to normative 
functioning, the reliable change index provides a measure of the magnitude of change over the 
course of treatment (Jacobson & Truax, 1991).  
Recovery status. Participants were classified as “recovered” if they met criteria for both 
clinically significant and reliable change (i.e., fell within normative range and showed real 
change), “improved” if they showed positive reliable change but did not end up in the normative 
range, and “deteriorated” if they showed negative reliable change regardless of whether they 
ended up in the normative range; participants who did not show reliable change were considered 
“unchanged” (Egan et al., 2014).  
Results 
Sample Descriptives 
 Mean age of the sample was 25.4 years (SD = 12.3). The majority of participants 
identified as female (74%), European American (85%), single (74%), and members of The 
Church of Jesus Christ of Latter-day Saints (79%; see Table 1 for details). The most common 
DSM-5 diagnoses assigned were OCPD, GAD, and OCD. There were no significant differences 
between groups on demographic, outcome, or process variables at pretreatment (see Table 1). 
There were significantly more participants diagnosed with GAD in the ACT condition than in the 
waitlist condition (p = .043). Baseline FMPS subscale scores in the current study were 
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comparable to those reported in previous clinical trials (e.g., Egan et al., 2014; Rozental et al., 
2017; Shafran et al., 2017), suggesting eligibility screening methods yielded a clinical sample. 
Treatment Dropout 
 Treatment dropout rate was high (35.7%) in the current study. Post hoc t-test analyses 
revealed no significant differences between completers and dropouts on primary outcome 
variables. However, the direction of between-group differences indicated participants who 
dropped out of treatment generally had higher mean scores of maladaptive perfectionism and 
symptom distress and lower mean scores on quality of life: FMPS-CM (Mcompleter = 32.1, Mdropout 
= 35.4, p = .305), FMPS-DA (Mcompleter = 14.9, Mdropout = 16.9, p = .139), OQ-45 (Mcompleter = 
75.5, Mdropout = 89.2, p = .106), and QOLS (Mcompleter = 78.5, Mdropout = 68.9, p = .177). 
Treatment Acceptability 
 The TEI-SF was only administered to participants in the ACT condition at the second 
session to avoid the confounding effect of treatment efficacy. The mean total score was 25.9 (SD 
=  3.3) out of a total possible score of 35, indicating moderately high treatment acceptability.  
Treatment Adherence 
 Mean ratings for ACT processes were as follows: acceptance = 3.29 (SD = 1.16), 
defusion = 2.76 (SD = 1.13), present moment awareness = 1.58 (SD = 0.60), self-as-context = 
1.16 (SD = 0.44), committed action = 2.76 (SD = 0.63), and values = 2.79 (SD = 0.96). This 
suggests treatment focused most heavily on acceptance, defusion, values, and committed action 
and these processes were covered several times in an in-depth manner. Mean scores for cognitive 
restructuring, attribution of causal power to internal experiences, and control/avoidance 
strategies were 1.00 (SD = 0), 1.03 (SD = 0.16), and 1.00 (SD = 0) respectively, indicating 
occurrence of ACT-inconsistent processes was extremely rare. The mean rating for adherence to 
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the ACT model was 4.68 (SD = 0.47) and that for overall therapist quality was 5.00 (SD = 0). 
These results suggest therapy in the present study was conducted in an ACT-consistent fashion 
and of excellent quality.  
Outcomes of Interest 
Means, standard deviations, and effect sizes for outcomes over time are presented in 
Table 2. 
Clinical Perfectionism (FMPS). Two of the three FMPS subscales showed a significant 
interaction between condition and time: FMPS-CM and FMPS-DA. For FMPS-CM, the 
conditions more strongly differed at posttreatment and follow-up (ps < .001; see Table 3). That 
is, as shown in Figure 2 Panel A, there was a greater decrease in scores in the ACT condition 
over time compared to the waitlist condition in which scores remained relatively constant. For 
FMPS-DA, there were lower scores in the ACT condition compared to the waitlist condition at 
posttreatment (p = .006) but not at one-month follow-up (see Figure 2 Panel B). Conversely, the 
best-fitting model for FMPS-PS only included time as a main effect; coefficients reflected a 
significant decrease in scores from pretreatment to follow-up—but not from pretreatment to 
posttreatment—across groups (p = .002; see Figure 2 Panel C). 
Symptom distress and functional impairment (OQ-45). The condition by time 
interaction was significant at both posttreatment and follow-up (p = .006 and p = .005 
respectively), suggesting that the decrease in self-reported distress and impairment in the ACT 
condition was maintained over time and greater than that in the waitlist condition (see Figure 2 
Panel D). 
Progress toward values (VQ). The interaction effect of time and condition was 
significant at posttreatment and follow-up (p < .001 and p = .011 respectively), with higher 
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scores for valued action observed in the ACT condition at both timepoints (see Figure 2 Panel 
E). 
Quality of life (QOLS). The interaction effect of time and condition was significant at 
posttreatment and follow-up (p = .016 and p < .001 respectively), with higher self-reported 
quality of life in the ACT condition at posttreatment and follow-up compared to the waitlist 
condition (see Figure 2 Panel F). 
Psychological inflexibility. he interaction effect of time and condition was significant at 
posttreatment and follow-up (p = .009 and p = .001 respectively). Self-reported psychological 
inflexibility significantly decreased in the ACT condition relative to the waitlist condition at 
posttreatment and follow-up (see Figure 2 Panel G). 
Self-compassion. The interaction between time and condition was significant for SCS 
scores at posttreatment and follow-up (p < .001 and p = .002 respectively), with the ACT 
condition showing greater self-reported self-compassion at both timepoints relative to the waitlist 
condition (see Figure 2 Panel H). 
Clinically Significant and Reliable Change   
Posttreatment. 2 tests indicated no significant between-group differences at 
posttreatment in the proportion of participants who demonstrated clinically significant change, 
reliable change, or overall improvement for FMPS-CM and OQ-45 (see Table 4). A higher 
proportion of participants in the ACT condition experienced clinically significant change in 
quality of life compared to the waitlist condition (89% vs. 58%; p = .034). For concern over 
mistakes, 45% in the ACT condition showed clinically significant change, 65% showed reliable 
improvement, and 35% were considered recovered. These figures were 67%, 77%, and 53% 
respectively for distress and impairment, and 89%, 65%, and 59% respectively for quality of life.  
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One-month follow-up. There were significant between-group differences for reliable 
change (p = .012) and recovery status (p = .030) for the FMPS-CM, clinically significant change 
for the OQ-45 (p = .010), and reliable change for the QOLS (p = .025; see Table 4 for details). 
Between-group differences tended to indicate both a higher proportion of ACT participants 
showing positive change and a smaller proportion of ACT participants showing no change or 
worsening of outcomes compared to waitlist participants at follow-up. For concern over 
mistakes, 50% in the ACT condition showed clinically significant change, 56% showed reliable 
improvement, and 44% were attained recovered status. These figures were 88%, 69%, and 63% 
respectively for distress and impairment, and 88%, 63%, and 56% respectively for quality of life. 
Discussion 
 Our findings indicate ACT was superior to a waitlist control condition on clinical 
perfectionism, psychological functioning, and processes of change from pretreatment to follow-
up. Within-group improvement over time was significant for all outcomes, further supporting the 
efficacy of ACT with respect to clinical perfectionism and global outcomes. In addition, the 
observed effect sizes are comparable to those obtained from CBT treatment trials for clinical 
perfectionism (Egan et al., 2014; Handley et al., 2015). For example, a previous waitlist-
controlled trial for individual CBT-P reported between-group posttreatment Hedges’ gs ranging 
from 0.49 to 1.16 for FMPS scales (Riley et al., 2007); corresponding effect sizes in the present 
study ranged from 0.42 to 1.05.  
Our results indicate ACT⎯as administered in the present study⎯may be similarly 
efficacious to CBT for clinical perfectionism based on comparisons of observed effect sizes and 
more efficacious than a waitlist condition on the most clinically relevant outcomes tested. Not 
only are these findings consistent with previous research that has found ACT to be effective in 
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treating related concerns like OCD (Twohig et al., 2010), mixed anxiety disorders (Arch et al., 
2012), and social anxiety (Craske et al., 2014), they also suggest ACT may be a viable treatment 
option for individuals struggling with clinical perfectionism more globally. Future research could 
clarify how the efficacy of ACT compares to CBT-P in the same trial and identify moderators of 
treatment response. Such findings would provide insight into the replicability of our findings and 
empirical guidance for clinical decision making regarding which treatment to use for clinical 
perfectionism. In addition, testing the efficacy of ACT for other overarching maladaptive 
processes (e.g., rumination) may be warranted. Results from these studies could be used to 
facilitate distillation of ACT protocols to their core function-oriented components and streamline 
therapeutic practice. Furthermore, given the role of clinical perfectionism as a risk and 
maintenance factor in various presentations (Egan et al., 2011), it would also be prudent to 
examine if reductions in perfectionism specifically predict decreases in psychopathology and 
functional outcomes to provide further evidence supporting clinical perfectionism as a 
generalized maladaptive process. 
More broadly, present findings provide evidence that a process-based approach—ACT in 
this case—can be useful for treating topographically diverse behavioral patterns that share a 
common function (e.g., avoidance of feelings of inadequacy). The present study represents a 
foray into the field of process-based care, which advocates a shift in focus from symptoms to 
malleable processes of change that cohere across levels of analysis, scientific disciplines, and 
worldviews in order to create more integrated evidence-based models of treatment (Hayes & 
Hofmann, 2017). By focusing our research and clinical efforts on mutable mechanisms of 
change, we can facilitate the development of more parsimonious interventions designed to 
address a wide range of formally distinct presentations by distilling them to core functional 
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processes. Such a transition may increase the efficiency of clinical training and psychological 
interventions, decreasing therapeutic burden on providers and clients and enhancing the 
availability of mental health resources (Hofmann & Hayes, 2018). 
 At the same time, we note that although doubting of actions did not significantly differ 
between groups at follow-up (Hedges’ g = -0.41), the ACT group reported significantly less 
doubting of actions at posttreatment (Hedges’ g = -0.74). The small change in personal standards 
observed is also congruent with results from previous treatment trials (Egan et al., 2014; Handley 
et al., 2015) and lack of significant group differences (Hedges’ g = -0.50 at posttreatment and -
0.36 at follow-up) could have been due to the slight decrease in the waitlist condition at follow-
up (see Figure 2 Panel C). The relatively small magnitude of change in personal standards is not 
unexpected from an ACT perspective. Given ACT therapists are concerned about the function of 
private events⎯including rules⎯rather than their frequency or content, it follows that a rule 
does not need to change for responses to it to change. In other words, participants could still have 
held high standards for themselves while practicing more flexible and adaptive responses to 
these rules. This interpretation is supported by the observed improvement in distress and 
impairment, quality of life, and psychological inflexibility in the ACT condition over time. 
Moreover, having high personal standards has been consistently linked to adaptive or healthy 
perfectionism (Bieling et al., 2004; Stoeber & Otto, 2006) so they may not need to change for 
individuals to live a meaningful life.  
In addition, gains in valued action at posttreatment were not maintained at follow-up. 
One reason for this could be valued behaviors are more situationally dependent than other 
indices of wellbeing, such as quality of life and self-compassion, and therefore more difficult to 
maintain. External barriers (e.g., being physically ill, being given a sudden work deadline) can 
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readily impede one’s ability to engage in specific actions. At the same time, external barriers are 
often tied to difficult inner experiences (e.g., rushing to meet a deadline to satisfy a perceived 
need to please others) and the capacity to persist in meaningful behavior in the presence of these 
inner experiences is a critical piece of psychological flexibility. Thus, future iterations of ACT 
for clinical perfectionism may need to emphasize behavioral maintenance more in therapy to 
increase the likelihood of sustained valued action. 
Limitations 
 Our results should be interpreted in the context of study limitations. First, our sample size 
was small. Use of multilevel analyses permitted use of all available data, minimizing issues with 
power and biases from study attrition, but error variability could still have obscured treatment 
effects, resulting in Type II error.  
Second, data were not collected from waitlist participants who chose to receive the 
intervention, which would have added power to within-group analyses. The reason for this 
decision was we did not believe the data collected from these participants for within-group 
analyses (between-group comparisons would have been inappropriate given groups would not 
have been independent) justified the additional burden placed on participants who had already 
completed one round of research assessment and who had been on a 14-week waitlist.  
Third, reliability analyses were not conducted for the screening measure used in the 
current study as screening data were collected prior to study enrollment. Thus, we were unable to 
ascertain the appropriateness of the DOCS Symmetry subscale for determining clinical status of 
our perfectionism sample. However, study eligibility was primarily evaluated using a clinical 
interview by a trained assessor and baseline perfectionism scores observed in our sample were 
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similar to those reported in previous clinical trials on perfectionism, indicating we obtained a 
sample with clinically significant levels of perfectionism. 
Fourth, our sample was homogenous (mostly White, college-aged, single, and LDS) and 
unrepresentative of population demographics, compromising generalizability of our findings. 
Furthermore, it is unclear if underlying processes necessarily replicate across dimensions of 
identity. It is possible marginalized individuals with a different set of contingencies in their 
history and current environment may have an alternative function for formally perfectionistic 
behaviors. If so, treatment would need to target that key function and the present protocol might 
not be applicable to these groups. For example, striving for high standards might be a response to 
consistent external doubts about personal abilities based on stereotypes rather than discomfort 
related to perceived failure and treatment may focus on empowerment and increased awareness 
of systemic oppression rather than clinical perfectionism per se.  
Fifth, although there are arguably advantages to using a waitlist control for initial pilot 
research evaluating new therapy applications (e.g., increasing power with smaller samples, 
reducing false negatives in early exploration; Gold et al., 2017), the waitlist condition did not 
rule out a variety of alternate method and common factors that might have accounted for 
treatment effects observed in this study (e.g., placebo and demand characteristics).  
Sixth, dropout rate in our study was relatively high (35.7%) compared to those in 
previous perfectionism trials (10% to 22.2%; Egan et al., 2014; Riley et al., 2007) as well as the 
average dropout rate in ACT of 15.8% (Ong, Lee, & Twohig, 2018). There were several possible 
reasons for this. The additional incentive of course credit might have resulted in dropout once 
students received a sufficient number of credits. Anecdotally, therapists noted a high level of 
disengagement and subsequent dropout following awarding of credit for completion of the 
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baseline assessment and early therapy sessions. Therapists also observed aspects of 
perfectionism (e.g., rigidity, avoidance) could have led to premature termination. For example, a 
few participants noted they were too busy with work to continue therapy. At the same time, the 
discrepancy between present dropout rate and that in other trials indicates high dropout is not 
unique to clinical perfectionism and dropout could have been lower in our sample. Therapists 
using a similar treatment may need to attend to factors contributing to dropout and explicitly 
address them in therapy to prevent early termination.  
Seventh, we did not conduct reliability tests for SCID diagnoses because we did not have 
a second independent interviewer. Ideally, a second interviewer blind to the first interviewer’s 
report should have conducted an independent assessment of diagnostic status. At the same time, 
given the process-based approach of the study intervention, the purpose of reporting DSM-5 
diagnoses was to provide a more detailed sample description rather than to evaluate treatment 
efficacy. Thus, although it is a limitation of our study, lack of reliability testing should not 
influence interpretation of current findings.  
Eighth, we did not preregister the current clinical trial, which may mar the credibility of 
our a priori hypotheses and subsequent findings as well as increase the probability of publication 
bias. Although we tested hypotheses stated in our research proposal, it would be prudent for 
researchers to preregister clinical trials to increase transparency in the research process and 
reduce potential reporting bias. 
Finally, a longer follow-up period would have provided more information on the 
longevity of treatment gains. This could be particularly important in the case of clinical 
perfectionism given many aspects of its presentation are ego-syntonic. Moreover, maladaptive 
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perfectionistic behavioral patterns tend to be longstanding and habitual, possibly rendering them 
more resistant to change and more prone to relapse.   
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Table 1 
Sample Descriptives  
 Overall 
(N = 53) 
ACT 
(n = 28) 
Waitlist 
(n = 25) 
pa 
Age 25.4 (12.3) 25.9 (13.9) 25.0 (10.5) .790 
Gender       .135 
Female 39 (73.6%) 23 (82.1%) 16 (64%)  
Male 14 (26.4%) 5 (17.9%) 9 (36%)  
Ethnicity       .463 
African American 1 (1.9%) 1 (3.6%) 0 (0%)  
Asian American 1 (1.9%) 0 (0%) 1 (4%)  
European American 45 (84.9%) 25 (89.3%) 20 (80%)  
Latinx/Hispanic 5 (9.4%) 2 (7.1%) 3 (12%)  
Other 1 (1.9%) 0 (0%) 1 (4%)  
Marital status      .421 
Single 39 (73.6%) 22 (78.6%) 17 (68%)  
Married 12 (22.6%) 5 (17.9%) 7 (28%)  
Divorced 1 (1.9%) 1 (3.6%) 0 (0%)  
Remarried 1 (1.9%) 0 (0%) 1 (4%)  
Employment status       .611 
Unemployed/not working 8 (15.1%) 4 (14.3%) 4 (16%)  
Working part-time 21 (39.6%) 10 (35.7%) 11 (44%)  
Working full-time 4 (7.5%) 1 (3.6%) 3 (12%)  
Full-time student 17 (32.1%) 11 (39.3%) 6 (24%)  
Retired 3 (5.7%) 2 (7.1%) 1 (4%)  
Education      .738 
M.A./M.S. or equivalent 3 (5.7%) 2 (7.1%) 1 (4%)  
Some graduate school 1 (1.9%) 1 (3.6%) 0 (0%)  
B.A/B.S. or equivalent 3 (5.7%) 2 (7.1%) 1 (4%)  
Associate degree 11 (20.8%) 5 (17.9%) 6 (24%)  
Some college 26 (49.1%) 12 (42.9%) 14 (56%)  
High school diploma or 
equivalent 
9 (17%) 6 (21.4%) 3 (12%)  
Religion       .359 
Catholic 2 (3.8%) 0 (0%) 2 (8%)  
LDS 42 (79.2%) 23 (82.1%) 19 (76%)  
Protestant (Christian) 1 (1.9%) 0 (0%) 1 (4%)  
Other 1 (1.9%) 1 (3.6%) 0 (0%)  
None 7 (13.2%) 4 (14.3%) 3 (12%)  
Diagnosis       
Social anxiety disorder 12 (22.6%) 8 (28.6%) 4 (16%) .275 
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Generalized anxiety disorder 31 (58.5%) 20 (71.4%) 11 (44%) .043 
Obsessive-compulsive 
disorder 
23 (43.4%) 10 (35.7%) 13 (52%) .232 
Hoarding disorder 4 (7.5%) 3 (10.7%) 1 (4%) .356 
Body dysmorphic disorder 2 (3.8%) 1 (3.6%) 1 (4%) .935 
Excoriation disorder 2 (3.8%) 1 (3.6%) 1 (4%) .935 
Binge eating disorder 2 (3.8%) 1 (3.6%) 1 (4%) .935 
Obsessive-compulsive 
personality disorder 
36 (67.9%) 21 (75%) 15 (60%) .243 
a Based on t-test for age and 2-test for all other demographic variables. 
Note. ACT = acceptance and commitment therapy; LDS = The Church of Jesus Christ of Latter-
day Saints.  
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Table 2 
Means, Standard Deviations, and Effect Sizes at Pretreatment, Posttreatment, and One-Month Follow-Up 
 ACT Waitlist Between Groups 
 Mean (SD) Hedges’ ga (95% CI) Mean (SD) Hedges’ ga (95% CI) Hedges’ g (95% CI) 
FMPS-CM      
Pretreatment 33.2 (8.4)  32.4 (6.4)   
Posttreatment 25.1 (6.2) -1.05 (-1.68, -0.42) 32.4 (7.5) -0.01 (-0.63, 0.62) -1.03 (-0.32, -1.73) 
Follow-up 25.3 (8.9) -0.91 (-1.57, -0.24) 33.2 (8.1) 0.11 (-0.57, 0.78) -0.90 (-1.69, -0.12) 
FMPS-DA      
Pretreatment 15.6 (3.5)  15.2 (2.4)   
Posttreatment 13.0 (3.4) -0.74 (-1.35, -0.13) 15.6 (3.1) 0.15 (-0.47, 0.77) -0.78 (-1.45, -0.11) 
Follow-up 13.3 (3.4) -0.64 (-1.29, 0.00) 14.8 (3.5) -0.13 (-0.81, 0.55) -0.41 (-1.17, 0.35) 
FMPS-PS      
Pretreatment 28.1 (5.5)  28.1 (5.0)   
Posttreatment 25.7 (5.8) -0.42 (-1.03, 0.18) 28.5 (5.2) 0.09 (-0.53, 0.71) -0.50 (-1.17, 0.16) 
Follow-up 
24.9 (5.7) 




-0.36 (-1.12, 0.39) 
OQ-45      
Pretreatment 80.6 (21.7)  75.2 (19.0)   
Posttreatment 55.5 (15.9) -1.26 (-1.93, -0.59) 68.3 (21.4) -0.34 (-0.97, 0.30) -0.67 (-1.36, 0.03) 
Follow-up 56.8 (17.2) -1.16 (-1.85, -0.47) 70.0 (23.0) -0.25 (-0.93, 0.44) -0.63 (-1.40, 0.14) 
VQ-Progress      
Pretreatment 15.2 (6.5)  17.2 (3.1)   
Posttreatment 23.3 (4.4) 1.38 (0.71, 2.05) 17.4 (3.9) 0.06 (-0.55, 0.68) 1.39 (0.64, 2.13) 
Follow-up 18.4 (7.0) 0.46 (-0.18, 1.10) 14.8 (5.3) -0.59 (-1.28, 0.10) 0.57 (-0.20, 1.33) 
QOLS      
Pretreatment 74.9 (15.7)  74.5 (11.8)   
Posttreatment 87.3 (12.9) 0.83 (0.19, 1.47) 76.7 (13.0) 0.18 (-0.44, 0.79) 0.80 (0.10, 1.49) 
Follow-up 86.7 (13.9) 0.76 (0.11, 1.42) 72.9 (13.5) -0.12 (-0.80, 0.55) 0.98 (0.18, 1.77) 
AAQ-II      
Pretreatment 31.9 (8.3)  29.6 (8.0)   
Posttreatment 21.9 (6.2) -1.31 (-1.98, -0.64) 26.9 (7.1) -0.35 (-0.97, 0.26) -0.73 (-1.42, -0.04) 
Follow-up 21.2 (7.5) -1.31 (-2.01, -0.62) 28.9 (10.0) -0.09 (-0.76, 0.59) -0.83 (-1.61, -0.05) 
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SCS      
Pretreatment 14.4 (3.7)  14.3 (3.1)   
Posttreatment 19.0 (3.1) 1.28 (0.60, 1.95) 15.4 (3.4) 0.36 (-0.27, 0.99) 1.06 (0.33, 1.80) 
Follow-up 18.4 (3.9) 1.03 (0.36, 1.70) 14.4 (3.8) 0.04 (-0.65, 0.73) 1.00 (0.19, 1.81) 
a Within-group effect sizes. 
Note. ACT = acceptance and commitment therapy; SD = standard deviation; CI = confidence interval; FMPS = Frost 
Multidimensional Perfectionism Scale; CM = Concern Over Mistakes; DA = Doubting of Actions; PS = Personal Standards; OQ-45 = 
Outcome Questionnaire-45.2; VQ = Valuing Questionnaire; QOLS = Quality of Life Scale; AAQ-II = Acceptance and Action 
Questionnaire⎯II; SCS = Self-Compassion Scale.  
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Table 3 
Coefficients for Best-Fitting Mixed Effects Models 
 FMPS-CM FMPS-DA FMPS-PS OQ-45 VQ-Progress QOLS AAQ-II SCS 
Intercept 33.25*** 15.61*** 28.10*** 80.96*** 15.25*** 75.26*** 32.06*** 14.40*** 
 (1.38) (0.60) (0.74) (3.70) (0.96) (2.64) (1.44) (0.63) 
Conditiona -0.81 -0.29  -6.05 1.95 -0.78 -2.42 -0.12 
 (2.02) (0.88)  (5.40) (1.40) (3.84) (2.09) (0.91) 
Posttreatment -7.34*** -2.45*** -1.14 -21.07*** 7.31*** 8.36*** -9.08*** 4.21*** 
 (1.36) (0.61) (0.62) (3.98) (1.28) (2.10) (1.71) (0.59) 
Follow-up -6.81*** -2.10** -2.21** -19.01*** 2.69* 7.64*** -9.54*** 3.36*** 
 (1.48) (0.66) (0.68) (4.11) (1.33) (2.16) (1.78) (0.61) 
Condition × Posttreatment 7.50*** 2.46**  16.00** -7.13*** -7.19* 6.37** -3.07*** 
 (1.98) (0.88)  (5.65) (1.80) (2.91) (2.38) (0.83) 
Condition × Follow-up 7.65*** 1.17  17.32** -5.05** -11.31*** 8.69*** -2.96*** 
 (2.17) (0.97)  (5.99) (1.95) (3.13) (2.58) (0.90) 
BIC 823.64 624.45 709.20 1029.79 758.11 929.47 833.60 600.57 
Log likelihood -392.64 -293.04 -342.63 -495.85 -359.90 -445.62 -397.69 -281.23 
Number of observations 121 121 120 117 120 119 119 117 
Number of participants 53 53 52 53 53 53 53 53 
a Reference group is waitlist. 
* p < .05. ** p < .01. *** p < .001. 
Note. FMPS = Frost Multidimensional Perfectionism Scale; CM = Concern Over Mistakes; DA = Doubting of Actions; PS = Personal 
Standards; OQ-45 = Outcome Questionnaire-45.2; VQ = Valuing Questionnaire; QOLS = Quality of Life Scale; AAQ-II = 
Acceptance and Action Questionnaire⎯II; SCS = Self-Compassion Scale; AIC = Akaike information criterion; BIC = Bayesian 
information criterion. 
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Table 4 
Clinically Significant and Reliable Change for Concern Over Mistakes, Distress and Impairment, and Quality of Life 
 Posttreatment One-Month Follow-up 
 
ACT 
(n = 20) 
Waitlist 
(n = 18) 
2 df p ACT 
(n = 16) 
Waitlist 
(n = 14) 
2 df p 
FMPS-CM           
Clinically significant 
change     
2.18 1 .140   1.4286 1 .232 
   Yes 9 (45%) 4 (22.2%)    8 (50%) 4 (28.6%)    
   No 11 (55%) 14 (77.8%)    8 (50%) 10 (71.4%)    
Reliable change     4.60 2 .100   8.8776 2 .012 
   Improved 13 (65%) 7 (38.9%)    9 (56.2%)   1 (7.1%)    
   No change 5 (25%) 4 (22.2%)    4 (25%) 10 (71.4%)    
   Worsened 2 (10%) 7 (38.9%)    3 (18.8%) 3 (21.4%)    
Recovery status     4.80 3 .187   8.978 3 .030 
   Recovered 7 (35%) 3 (16.7%)    7 (43.8%)   1 (7.1%)    
   Improved 6 (30%) 4 (22.2%)    2 (12.5%)   0 (0%)    
   Unchanged 5 (25%) 4 (22.2%)    4 (25%) 10 (71.4%)    
   Deteriorated 2 (10%) 7 (38.9%)    3 (18.8%)   3 (21.4%)    
OQ-45           
Clinically significant 
change     
0.12 1 .729   6.6964 1 .010 
   Yes 12 (66.7%) 11 (61.1%)    14 (87.5%)  6 (42.9%)    
   No  6 (33.3%) 7 (38.9%)    2 (12.5%)   8 (57.1%)    
Reliable change     5.86 2 .053   3.5611 2 .169 
   Improved 13 (76.5%) 6 (35.3%)    11 (68.8%)  5 (35.7%)    
   No change 2 (11.8%) 5 (29.4%)    3 (18.8%) 4 (28.6%)    
   Worsened 2 (11.8%) 6 (35.3%)    2 (12.5%)   5 (35.7%)    
Recovery status     5.88 3 .118   5.4219 3 .143 
   Recovered 9 (52.9%) 4 (23.5%)    10 (62.5%)  3 (21.4%)    
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   Improved 4 (23.5%) 2 (11.8%)    1 (6.2%) 2 (14.3%)    
   Unchanged 2 (11.8%) 5 (29.4%)    3 (18.8%)   4 (28.6%)    
   Deteriorated 2 (11.8%) 6 (35.3%)    2 (12.5%)   5 (35.7%)    
QOLS           
Clinically significant 
change     
4.50 1 .034   2.2493 1 .134 
   Yes 16 (88.9%) 11 (57.9%)    14 (87.5%)  9 (64.3%)    
   No  2 (11.1%) 8 (42.1%)    2 (12.5%)   5 (35.7%)    
Reliable change     5.97 2 .051   7.4117 2 .025 
   Improved 11 (64.7%) 5 (26.3%)    10 (62.5%)  3 (21.4%)    
   No change 5 (29.4%) 9 (47.4%)    4 (25%)  3 (21.4%)    
   Worsened 1 (5.9%) 5 (26.3%)    2 (12.5%)   8 (57.1%)    
Recovery status     6.29 3 .098   7.6435 3 .054 
   Recovered 10 (58.8%) 4 (21.1%)    9 (56.2%)   3 (21.4%)    
   Improved 1 (5.9%) 1 (5.3%)    1 (6.2%) 0 (0%)    
   Unchanged 5 (29.4%) 9 (47.4%)    4 (25%) 3 (21.4%)    
   Deteriorated 1 (5.9%) 5 (26.3%)    2 (12.5%)   8 (57.1%)    
Note. Statistically significant between-group differences at p < .05 are bolded. ACT = acceptance and commitment therapy; FMPS = 
Frost Multidimensional Perfectionism Scale; CM = Concern Over Mistakes; OQ-45 = Outcome Questionnaire-45.2; QOLS = Quality 
of Life Scale.  
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Figure 1. Flowchart depicting participant eligibility, dropout, and session attendance.  
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Figure 2. Plots of changes in outcomes over time. Vertical bars represent standard errors. ACT = 
acceptance and commitment therapy; FMPS = Frost Multidimensional Perfectionism Scale; OQ-
45 = Outcome Questionnaire-45.2; VQ = Valuing Questionnaire; QOLS = Quality of Life Scale; 
AAQ-II = Acceptance and Action Questionnaire⎯II; SCS = Self-Compassion Scale. 
 
